| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CEO, Pres, CFO, Treas &Secy | CFO And Secretary
1 company
Kenyon Lawrence A is a Chief Financial Officer at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 3 sells.
Estimated insider holdings value: $9K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | OTLK Outlook Therapeutics, Inc. | Chief Financial Officer | Buy | 5,000 | $5.69 | $28,446.00 | +528.5% | -70.1% | -82.9% | |
| Apr 20, 2021 | OTLK Outlook Therapeutics, Inc. | CEO, Pres, CFO, Treas &Secy | Buy | 10,000 | $1.83 | $18,300.00 | +112.0% | +32.0% | +1.7% | |
| Sep 18, 2019 | OTLK Outlook Therapeutics, Inc. | CEO, Pres, CFO, Treas &Secy | Sell | 1,350 | $1.70 | $2,295.00 | -1.6% | - | - | |
| Feb 7, 2019 | OTLK Outlook Therapeutics, Inc. | CEO, Pres, CFO, Treas &Secy | Buy | 25,000 | $0.90 | $22,380.00 | +43.7% | - | - | |
| Sep 18, 2018 | OTLK Outlook Therapeutics, Inc. | CEO, Pres, CFO, Treas &Secy | Sell | 10,100 | $0.87 | $8,807.20 | -15.0% | - | - | |
| Dec 22, 2017 | OTLK Outlook Therapeutics, Inc. | CFO And Secretary | Sell | 26,165 | $1.13 | $29,566.45 | -28.0% | - | - |